ATOSSA THERAPEUTICS I
1.5000
08-11月-24 14:59:57
15 分の遅延
株式
0.0000
0.00%
本日の幅
1.4500 - 1.5050
ISIN
N/A
ソース
NASDAQ
-
05 11 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Reports Positive KARISMA-Endoxifen Trial Results:
04 11 2024 05:30:00 提供 Nasdaq GlobeNewswire
-
31 10 2024 07:15:00 提供 Nasdaq GlobeNewswire
-
21 10 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics to Present at the 2024 Maxim Healthcare Virtual Summit
14 10 2024 16:08:43 提供 Nasdaq GlobeNewswire
-
01 10 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
03 9 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Granted Additional Patent Protection for Endoxifen
28 8 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
21 8 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
20 8 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update
12 8 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer
02 7 2024 15:15:00 提供 Nasdaq GlobeNewswire
-
28 6 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Atossa Set to Join Russell 3000® Index Effective June 28, 2024
17 6 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Atossa to Present at the Sidoti Small-Cap Investor Conference
05 6 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
28 5 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
15 5 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
13 5 2024 07:50:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >